Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin

Metabolism: Clinical and Experimental

Volumn 60, Issue 12, 2011, Pages 1683-1691

  Lautenslager, Gregory T ^a   Shearman, Clyde W ^a   Hud, Elizabeth ^a   Cohen, Margo P ^a  

^a Glycadia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; HUMAN SERUM ALBUMIN; LINOLEIC ACID; OLEIC ACID; PALMITIC ACID; WARFARIN;

ARTICLE; BINDING AFFINITY; FLUORESCENCE; GLYCATION; LIGAND BINDING; LIPID TRANSPORT; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STRUCTURE;

DANSYL COMPOUNDS; FATTY ACIDS, UNSATURATED; FLUORESCENCE; GLYCOSYLATION; HUMANS; LINOLEIC ACID; OLEIC ACID; PALMITIC ACID; SARCOSINE; SERUM ALBUMIN; WARFARIN;

EID: 81155137750     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.03.022     Document Type: Article

References (47)

1. C.G. Schalkwijk, N. Ligtvoet, and H. Twaalfhoven Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries Diabetes 48 1999 2446 2453 (Pubitemid 30395438)
2. C.G. Schalkwijk, N. Chaturvedi, and H. Twaalfhoven EUCLID study group. Amadori-albumin correlates with macrovascular complications and precedes diabetic nephropathy in type 1 diabetic patients Eur J Clin Invest 32 2002 500 506 (Pubitemid 36223420)
3. N. Chaturvedi, C.G. Schalkwijk, and H. Abrahamian Circulating and urinary transforming growth factor-β1, Amadori albumin, and complications of type 1 diabetes: the EURODIAB prospective complications study Diabetes Care 25 2002 2320 2327
4. Z.M. Bian, S.G. Elner, and R.M. Strieter Glycated serum albumin induces chemokine gene expression in human retinal pigment epithelial cells J Leukoc Biol 60 1996 405 414 (Pubitemid 26325623)
5. P.A. Campochiaro Cytokine production by retinal pigmented epithelial cells Int Rev Cytol 146 1993 75 82 (Pubitemid 23286700)
6. Z.M. Bian, V.M. Elner, and N.W. Lukacs Glycated human serum albumin induces IL-8 and MCP-1 gene expression in human corneal keratocytes Curr Eye Res 17 1998 65 72 (Pubitemid 28039670)
7. V.M. Elner, M.A. Burnstine, and R.M. Strieter Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in situ hybridization analyses Exp Eye Res 65 1997 781 789 (Pubitemid 28053603)
8. Z.M. Bian, V.M. Elner, and A. Yoshida Signaling pathways for glycated human serum albumin-induced IL-8 and MCP-1 secretion in human RPE cells Invest Ophthalmol Vis Sci 42 2001 1660 1668 (Pubitemid 32520762)
9. M.P. Cohen, and F.N. Ziyadeh Amadori glucose adducts modulate mesangial cell growth and collagen gene expression Kidney Int 45 1994 475 484 (Pubitemid 24065083)
10. F.N. Ziyadeh, D. Han, and J.A. Cohen Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-β system Kidney Int 53 1998 631 638 (Pubitemid 28124277)
11. M. Cohen, F.N. Ziyadeh, and G.T. Lautenslager Glycated albumin stimulation of PKC-β activity is linked to increased collagen IV production in mesangial cells Am J Physiol Renal Physiol 276 1999 F684 F690
12. S. Chen, M.P. Cohen, and G.T. Lautenslager Glycated albumin stimulates TGF-β1 production and protein kinase C activity glomerular endothelial cells Kidney Int 59 2001 673 681 (Pubitemid 32157932)
13. S. Doublier, G. Salvidio, and E. Lupia Nephrin expression is reduced in human diabetic nephropathy. Evidence for a distinct role for glycated albumin and angiotensin II Diabetes 52 2003 1023 1030 (Pubitemid 36384273)
14. L. Oettl, and R.E. Stauber Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties Br J Pharmacol 151 2007 580 590 (Pubitemid 47016287)
15. T. Peters All about albumin: biochemistry, genetics and medical applications 1996 Academic Press San Diego
16. M. Fasano, S. Curry, and E. Terreno The extraordinary ligand binding properties of human serum albumin IUBMB Life 57 2005 787 796 (Pubitemid 43062399)
17. N. Shaklai, R.L. Garlick, and H.F. Bunn Nonenzymatic glycosylation of human serum albumin alters its conformation and function J Biol Chem 259 1984 3812 3817 (Pubitemid 14170093)
18. W. Worner, S. Pfeiderer, and W. Kratzer Nonenzymatic glycation of human serum albumin: influence on the binding kinetics of the benzodiazepine binding sites J Clin Chem Biochem 28 1990 527 531 (Pubitemid 20281866)
19. Y. Keita, W. Kratzer, and W. Worner Effect of free fatty acids on the binding kinetics at the benzodiazepine binding site of glycated human serum albumin Int J Clin Pharmacol Ther Toxicol 31 1993 337 342 (Pubitemid 23223379)
20. K. Nakajou, H. Watanabe, and U. Kragh-Hansen The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants Biochim Biophys Acta 1623 2003 88 97 (Pubitemid 37315665)
21. E. Yamazaki, M. Inagaki, and O. Kurita Kinetics of fatty acid on binding ability of glycated human serum albumin Biosciences 3 2007 475 481
22. N. Okabe, and N. Hashizume Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism Br Pham Bull 17 1994 16 21 (Pubitemid 24056977)
23. J.P. Bohney, and R.C. Feldhoff Effects of nonenzymatic glycosylation and fatty acids on tryptophan binding to human serum albumin Biochem Pharmacol 43 1992 1829 1834
24. K.A. Mereish, H. Rosenberg, and J. Cobby Glucosylated albumin and its influence on salicylate binding J Pharm Sci 71 1982 234 238
25. M.P. Cohen, F.N. Ziyadeh, and S.W. Hong Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-β1 Kidney Int 6l 2002 2025 2032 (Pubitemid 34539320)
26. M.P. Cohen, S. Chen, and F.N. Ziyadeh Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression and proteinuria in diabetes Kidney Int 68 2005 1554 1561 (Pubitemid 43169900)
27. M.P. Cohen, G.T. Lautenslager, and E. Hud Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency Am J Physiol Renal Physiol 292 2007 F789 F795
28. M.P. Cohen, E. Hud, and V.Y. Wu Amelioration of diabetes-associated abnormalities in the vitreous fluid by an inhibitor of albumin glycation Invest Ophthalmol Vis Sci 49 2008 5089 5093
29. L. Kennedy, M.P. Solano, and L. Meneghini Anti-glycation and anti-albuminuric effects of GLY-230 in human diabetes Am J Nephrol 3 2010 101 116
30. J. Ghuman, P.A. Zunszain, and I. Petitpas Structural basis of the drug-binding specificity of human serum albumin J Mol Biol 353 2005 38 52 (Pubitemid 41338838)
31. U. Kragh-Hansen Structure and ligand binding properties of human serum albumin Dan Med Bull 37 1990 57 84
32. J.R. Simard, P.A. Zunszain, and J.A. Hamilton Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis J Mol Biol 361 2006 336 351 (Pubitemid 44092787)
33. C. Sudlow, D.J. Birkett, and D.M. Wade Further characterization of specific drug binding sites on human serum albumin Mol Pharmacol 12 1976 1052 1061
34. U. Kragh-Hansen, V.T.A. Chuang, and M. Otagiri Practical aspects of the ligand binding and enzymatic properties of human serum albumin Biol Pharm Bull 25 2002 695 704 (Pubitemid 40036701)
35. R.L. Garlick, and J.S. Mazer The principal site of nonenzymatic glycosylation of human serum albumin in vivo J Biol Chem 258 1983 6142 6146 (Pubitemid 13106789)
36. M.P. Cohen, and E. Hud Production and characterization of monoclonal antibodies against human glycoalbumin J Immunol Methods 117 1989 121 129 (Pubitemid 19038726)
37. T. Sudlow, D.J. Birkett, and D.N. Wade Spectroscopic techniques in the study of protein binding: the use of 1-anilino-8-naphthalenesulphonate as a fluorescent probe for the study of the binding of iophenoxic and iopanoic acids to human serum albumin Mol Pharmacol 9 1973 649 657
38. A. Saifer, and L. Goldman The free fatty acids bound to human serum albumin J Lipid Res 2 1961 268 270
39. H. Olsen, A. Andersen, and A. Nordbo Pharmaceutical grade albumin: impaired drug binding capacity in vitro BMC Clin Pharmacol 4 2004 4 12
40. N. Iberg, and R. Fluckiger Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites J Biol Chem 261 1986 13542 13545 (Pubitemid 17196372)
41. S. Sugio, A. Kashima, and S. Mochizuki Crystal structure of human serum albumin at 2.5A resolution Protein Eng 12 1999 439 446 (Pubitemid 29322441)
42. J.E. Walker Lysine residue 199 of human serum albumin is modified by acetylsalicylic acid FEBS Lett 66 1976 173 175
43. D.C. Wilton The fatty acid analogue 11-(dansylamino) undecanoic acid is a fluorescent probe for the bilirubin-binding sites of albumin and not for the high-affinity fatty acid-binding sites Biochem J 270 1990 163 166 (Pubitemid 20275591)
44. E.A.E. Thumser, A.G. Buckland, and D.C. Wilton Monoacylglycerol binding to human serum albumin: evidence that monoacylglycerol binds at the dansylsarcosine site J Lipid Res 349 1998 1033 1038 (Pubitemid 28222008)
45. H. Vorum, and B. Honore Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy J Pharm Pharmacol 48 1996 870 875 (Pubitemid 26335272)
46. I. Petitpas, A.A. Bhattacharya, and S. Twine Crystal structure analysis of warfarin binding to human serum albumin J Biol Chem 276 2001 22804 22809
47. R. Salazar, R. Brandt, and J. Kellerman Purification and characterization of a 200 kDa fructosyllysine-specific binding protein from cell membranes of U937 cells Glycoconj J 17 2000 713 716 (Pubitemid 32493949)